Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Johnson & Johnson Announces Opening of Boston Innovation Center

PR Newswire June 27, 2013

FDA Reviews, Acquisitions, Dividends, and Drug Study Results Highlight Solid Growth for Major Drug Companies - Research Report on Pfizer, Johnson & Johnson, Zoetis, AbbVie, and Lilly

PR Newswire June 26, 2013

Johnson & Johnson to Host Conference Call on Second-Quarter Results

PR Newswire June 25, 2013

Cordis Announces Additional Sizes of SLEEK® OTW Platform

Business Wire June 24, 2013

SodaStream, Statoil, Nektar Therapeutics, Johnson & Johnson and Pfizer highlighted as Zacks Bull and Bear of the Day

PR Newswire June 21, 2013

Early Morning Insight: Pfizer, Merck & Co., Johnson & Johnson, AbbVie, and Zogenix

PR Newswire June 20, 2013

The Zacks Analyst Blog Highlights: Chevron, Johnson & Johnson, Google, Coca-Cola and Automatic Data Processing

PR Newswire June 20, 2013

Before the Crowd, How We Found SFD, AIG and JNJ

Marketwired June 18, 2013

Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.

PR Newswire June 17, 2013

The Real Story Behind AIG, KO, JNJ and PG

Marketwired June 17, 2013

New 1-DAY ACUVUE® TruEye® Brand Contact Lenses (narafilcon A) Now Available In U.S.

PR Newswire June 13, 2013

Cordis Announces FDA Clearance of the ADROIT(TM) Guiding Catheter

Business Wire June 12, 2013

David Julius Wins 2013 Dr. Paul Janssen Award for Biomedical Research

PR Newswire June 12, 2013

Research Study Results Bring Hope for Combating Debilitating Diseases - Research Report on Johnson & Johnson, AbbVie, Lilly, Novartis and GlaxoSmithKline

PR Newswire June 12, 2013

Perfect Trade Setups, How to Play JNJ, CRM, SAI and GME

Marketwired June 12, 2013

Two Investment Opportunities in One Medical Device Company

Accesswire June 11, 2013

Regenerative Medicine Investors Eyeing Reformation of Pharmaceutical Affairs Law in Japan

Accesswire June 10, 2013

The Reason It Trades, What's Moving QCOM, MDLZ, JNJ and DHI

Marketwired June 7, 2013

Key to Success, How to Profit: DAL, PWE, JNJ and ANR

Marketwired June 6, 2013

DECN Steps Into Role of White Knight by Offering Strategic Version of GenStrip(TM) Exclusively for Medicare Competitive Bidding Program

Marketwired May 29, 2013